Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).

MLA

Horn, A., et al. “Long-Term Health Sequelae and Quality of Life at Least 6 Months after Infection with SARS-CoV-2: Design and Rationale of the COVIDOM-Study as Part of the NAPKON Population-Based Cohort Platform (POP).” Infection, vol. 49, no. 6, Dec. 2021, pp. 1277–87. EBSCOhost, https://doi.org/10.1007/s15010-021-01707-5.

APA

Horn, A., Krist, L., Lieb, W., Montellano, F. A., Kohls, M., Haas, K., Gelbrich, G., Bolay-Gehrig, S. J., Morbach, C., Reese, J. P., Störk, S., Fricke, J., Zoller, T., Schmidt, S., Triller, P., Kretzler, L., Rönnefarth, M., Von Kalle, C., Willich, S. N., & Kurth, F. (2021). Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection, 49(6), 1277–1287. https://doi.org/10.1007/s15010-021-01707-5

Chicago

Horn, A., L. Krist, W. Lieb, F. A. Montellano, M. Kohls, K. Haas, G. Gelbrich, et al. 2021. “Long-Term Health Sequelae and Quality of Life at Least 6 Months after Infection with SARS-CoV-2: Design and Rationale of the COVIDOM-Study as Part of the NAPKON Population-Based Cohort Platform (POP).” Infection 49 (6): 1277–87. doi:10.1007/s15010-021-01707-5.